Home LiteratureArticle Details
PMID: 40538723 Published · epublish English Journal Article

A retrospective report on xenotransfusion of canine serum albumin in five critically ill cats.

Frontiers in veterinary science ·Vol. 12 ·2025-00-00 ·页码 1585988

Sirabian E, Walton RA, Blong AE

Abstract

This retrospective case series describes the xenotransfusion of canine serum albumin (CSA) in five critically ill cats. Four cats received a single xenotransfusion of CSA, while one cat received two separate xenotransfusions. Overall, two out of five cats (40%) survived long enough to be discharged, which is similar to previously published survival rates for critically ill cats. One cat exhibited clinical signs attributable to acute transfusion-associated circulatory overload (TACO), while two cats showed clinical signs suggestive of a possible, although less likely, transfusion reaction. While a prospective study is needed, the review of the cases presented here suggests that CSA may provide oncotic and hemodynamic support and be safe to administer to critically ill cats.

Keywords
albumin canine albumin feline hypoalbuminemia xenotransfusion
作者与单位
共 3 位作者,点击展开单位 / ORCID
Sirabian Eric
College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
Walton Rebecca A
College of Veterinary Medicine, Iowa State University, Ames, IA, United States. | VCA West Los Angeles Animal Hospital, Los Angeles, CA, United States.
Blong April E
College of Veterinary Medicine, Iowa State University, Ames, IA, United States.
Article Info
Journal
Frontiers in veterinary science
Abbr.
Front Vet Sci
ISSN
2297-1769
Published
2025-00-00
电子出版
2025-00-05
页码
1585988
Language
English
Country/Region
Switzerland
NLM ID
101666658
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]